TCL Archive ‘We Cannot Tolerate One Third Reduction In Centers. Prevention, Clinical Trials Programs’ September 20, 1991
TCL Archive Tasigna Shows High Response, PFS Benefit Compared to Gleevec in Phase III CML Study December 26, 2014
TCL Archive Congress Orders Programs In Nutrition Research; Cancer Act Extension Beefs Up NCI Chief’s Authority July 12, 1974